Literature DB >> 16293848

Adjuvant trastuzumab for breast cancer: advent of pharmacogenetics raises many issues.

Hazel Thornton.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16293848      PMCID： PMC1285139          DOI： 10.1136/bmj.331.7526.1202-a

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  1 in total

1.  Adjuvant trastuzumab for breast cancer.

Authors:  Rebecca Dent; Mark Clemons
Journal:  BMJ       Date:  2005-11-05
  1 in total
  1 in total

Review 1.  Current controversies in the management of early breast cancer.

Authors:  L G Estévez; M Martín; E Alba; R Colomer; F Lobo; A Lluch; E Adrover; J Albanell; A Barnadas; J García-Mata; A Llombart; M Muñoz; C Rodríguez; P Sánchez-Rovira; M A Seguí; I Tusquets
Journal:  Clin Transl Oncol       Date:  2007-06       Impact factor: 3.340
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.